Omega Healthcare Investors
S&P 400
$46.99
+0.09%
Delayed · cached 15 min
Fair value analysis
OHI
Omega Healthcare Investors
$46.99
Close used for this calculation
$27.39Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
49/100
Quality radar
Consensus fair value
$27.39
Above FV▼ -41.7% against the close used
Model range $1.94 – $38.80
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$1.94Fair value$27.39Bull$38.80
FairClose
52-week traded range
52W low $39.4152W high $51.72
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Omega Healthcare Investors closed at $46.99, 71.6% above the consensus fair value of $27.39 drawn from 9 valuation models.
Financial DNA score 49/100 — Average. P/E of 24.2x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$24.29
-48.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=1%, r=10%, tg=3%, n=10yr
Graham Number
$27.26
-42.0%
√(22.5 × EPS × BVPS)
EPS=1.94, BVPS=17.03 · outside Graham range (P/E 24.2, P/B 2.8) — asset-light, treat as a rough floor
P/E Fair Value
$38.80
-17.4%
EPS × 20x (sector P/E)
EPS=1.94, Sector P/E=20x
Peter Lynch (PEG)
$1.94
-95.9%
EPS × Growth% (PEG = 1 is fair)
EPS=1.94, g=1%
EV/EBITDA
$18.87
-59.8%
(EBITDA × 10.5x − Net Debt) ÷ Shares
EBITDA=949.46M
Dividend Discount (DDM)
$34.15
-27.3%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=2.68, r=10%, g=2%
Book Value (P/B)
$19.34
-58.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=17.03, ROE=11%, g=3%, r=10%
Reverse DCF
$46.99
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 9.7% | Historical: 1%
Margin of Safety
$22.59
-51.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=30.12, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.